Thus, Yi et al. [55] reported that transgenic mice lacking DAL-1 do not develop tumors, and Nunes et al. [56] reported that only 12/62 (19%) meningiomas had LOH of DAL-1, 11 of such 12 cases also showing LOH of the NF2 gene. The gene discussed is NF2; the disease is meningioma.